Clinical Trial

Role of Metformin in Posterior Capsule Opacification

Name: Role of Metformin in Posterior Capsule Opacification — clinical trial record (NCT07176338)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated September 16, 2025 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.

Summary

Determination of concentrations of systemically applied metformin in human lens capsule and its ability to lower the proliferation rate of human lens epithelial cells in vitro.

Trial Details

NCT Number	NCT07176338
Lead Sponsor	Vienna Institute for Research in Ocular Surgery
Conditions	Cataract, Diabetes Mellitus Type 2
Enrollment	40 participants
Start Date	2022-10-12
Primary Completion	2025-10-01 (estimated)
Study Completion	2025-10-01 (estimated)
Updated on ClinicalTrials.gov	2025-09-16